Font Sizes: A A A

Zoltan Varga

Present appointment: assistant professor

Phone: +36 1 210 29 30/56265

Email: varga

Education and qualification:

  • 2003-2009 University of Szeged, Faculty of Medicine, Szeged
  • 2009-2011: English – Hungarian medical communication, University of Szeged, Faculty of Medicine, Szeged

Present affiliation:
2018-  Assistant Professor, Dept. of Pharmacology and Pharmacotherapy, Semmelweis University, Budapest, Hungary

Previous appointments:

  • 2015-2018            Visiting Fellow, Laboratory of Cardiovascular Physiology and Tissue Injury, National Institutes of Health, National Institute on Alcohol Abuse and Alcoholism, Bethesda, Maryland, USA.
  • 2013-2015            Assistant Professor, Dept. of Pharmacology and Pharmacotherapy, Semmelweis University, Budapest, Hungary
  • 2012-2013            Research Associate, Cardiometabolic Research Group, Dept. of Pharmacology and Pharmacotherapy, Semmelweis University, Budapest, Hungary

Scientific degree:

2013                PhD, University of Szeged (Summa cum laude)

Spoken foreign languages:

  • Englilsh
  • German

Educational activities:
Graduate education:

  • 2012- Pharmacology seminars for medical and dentistry students (hungarian, english language)
  • 2005-2012 Biochemistry practices for medical and dentistry students (hungarian, english and german language)

Fellowships, awards:

  • 2018.      Premium Postdoctoral Fellowship, Hungarian Academy of Sciences
  • 2017.      Junior Prima Award
  • 2013.      Award of Merit (Semmelweis University)
  • 2014.      Rosztoczy Foundation Postdoctoral Fellowship

Membership

  • International Society for Heart Research (ISHR)
  • Hungarian Society for Cardiology
  • European Society for Cardiology (working groups: Myocardial Function, Cellular Biology of the Heart)
  • International Cannabinoid Research Society
  • Hungarian Society for Experimental and Clinical Pharmacology 
  • Research Society on Alcoholism

Scientific interest:

Molecular and cellular cardiology, cardiovascular immunology: investigations in metabolic diseases, in ischemia/reperfusion injury, and in heart failure.

Grants (principal investigator):

  • 2018-2021                   MTA PPD 9 (29 M HUF)
  • 2017-2018                   SE Startup-17 (22 M HUF)

Scholarships

  • 2011 Institut für Experimentelle Pharmakologie und Toxikologie, Universitätsklinikum Hamburg-Eppendorf, Hamburg, Germany
  • 2013 Laboratory of Physiological Studies, NIAAA, National Institutes of Health, Bethesda, Maryland, USA

Scientometric data:

  • Google scholar
  • Cumulative impact factor: over 300
  • Number of citations: 967
  • Hirsch-index: 16
  • Book chapters: 1
  • Patents: 1